| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.068 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |